000 | 01620 a2200433 4500 | ||
---|---|---|---|
005 | 20250515162144.0 | ||
264 | 0 | _c20100903 | |
008 | 201009s 0 0 fre d | ||
022 | _a0151-9638 | ||
024 | 7 |
_a10.1016/S0151-9638(08)75486-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFrancès, C | |
245 | 0 | 0 |
_a[What's new in internal medicine?]. _h[electronic resource] |
260 |
_bAnnales de dermatologie et de venereologie _cDec 2008 |
||
300 |
_aS335-42 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
650 | 0 | 4 |
_aAutoimmune Diseases _xcomplications |
650 | 0 | 4 |
_aBacteriophages _xisolation & purification |
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 | _aDiabetes Complications |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxychloroquine _xtherapeutic use |
650 | 0 | 4 |
_aHypereosinophilic Syndrome _xdrug therapy |
650 | 0 | 4 |
_aHypertension _xcomplications |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aInternal Medicine _xtrends |
650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
650 | 0 | 4 |
_aMimiviridae _xisolation & purification |
650 | 0 | 4 |
_aObesity _xcomplications |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVenous Thromboembolism _xdrug therapy |
773 | 0 |
_tAnnales de dermatologie et de venereologie _gvol. 135 Suppl 7 _gp. S335-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0151-9638(08)75486-3 _zAvailable from publisher's website |
999 |
_c18704682 _d18704682 |